Evidence map›Paper›PMID 27861626›Full record

ArticlePloS one2016

Image Quality and Stenosis Assessment of Non-Contrast-Enhanced 3-T Magnetic Resonance Angiography in Patients with Peripheral Artery Disease Compared with Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography.

Jiayi Liu, Nan Zhang, Zhaoyang Fan, Nan Luo, Yike Zhao, Xiaoming Bi, Jing An, Zhong Chen, Dongting Liu, Zhaoying Wen and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Noncontrast MR angiography: An update.Journal of magnetic resonance imaging : JMRI · 2019
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Jiayi LiuDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Nan ZhangDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Zhaoyang FanBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Nan LuoDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Yike ZhaoDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Xiaoming BiBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Jing AnSiemens Healthcare, China, MR Collaborations NE Asia, Beijing, China.
Zhong ChenDepartment of Vascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Dongting LiuDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Zhaoying WenDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Zhanming FanDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Chaoyang District Anzhen Road 2nd, Beijing, 100029, China.
Debiao LiBiomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
Capital Medical University · CNCedars-Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the diagnostic performance of flow-sensitive dephasing (FSD)-prepared steady-state free precession (SSFP) magnetic resonance angiography (MRA) at 3 T for imaging infragenual arteries relative to contrast-enhanced MRA (CE-MRA) and digital subtraction angiography (DSA). MATERIALS AND

methodsA series of 16 consecutive patients with peripheral arterial disease (PAD) underwent a combined peripheral MRA protocol consisting of FSD-MRA for the calves and large field-of-view CE-MRA. DSA was performed on all patients within 1 week of the MR angiographies. Image quality and degree of stenosis was assessed by two readers with rich experience. Inter-observer agreement was determined using kappa statistics. Receiver operating characteristic (ROC) curve analysis determined the diagnostic value of FSD-MRA, CE-MRA, and CE-MRA combined with FSD-MRA (CE+FSD MRA) in predicting vascular stenosis.

resultsAt the calf station, no significantly difference of subjective image quality scores was found between FSD-MRA and CE-MRA. Inter-reader agreement was excellent for both FSD-MRA and CE-MRA. Both of FSD-MRA and CE-MRA carry a stenosis overestimation risk relative to DSA standard. With DSA as the reference standard, ROC curve analysis showed that the area under the curve was largest for CE+FSD MRA. The greatest sensitivity and specificity were obtained when a cut-off stenosis score of 2 was used.

conclusionIn patients with severe PAD,3 T FSD-MRA provides good-quality diagnostic images without a contrast agent and is a good supplement for CE-MRA. CE+FSD MRA can improve the accuracy of vascular stenosis diagnosis.

Indexed as

Contrast MediaImage EnhancementAdolescentAdultAgedAged, 80 and overFemaleHumansImage Processing, Computer-AssistedImaging, Three-DimensionalMagnetic Resonance AngiographyMaleMiddle AgedPatient SelectionPeripheral Arterial DiseaseReproducibility of ResultsContrast Media

Identifiers

PMID27861626
PMCPMC5115740
OpenAlexW2550185329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.